Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

134.53
-6.4500-4.58%
Post-market: 135.751.22+0.91%19:59 EDT
Volume:170.28K
Turnover:24.09M
Market Cap:26.91M
PE:- -
High:151.32
Open:130.36
Low:130.36
Close:140.98
52wk High:165.00
52wk Low:14.95
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.73
T/O Rate:85.14%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Nanexa, Forge Nano Enter Joint Development Deal on GMP-Scale ALD Equipment for PharmaShell Injectables

Reuters
·
Sep 22

Moderna Surges 12% to a New 52-Week High as Phase 3 Cancer Vaccine Data Set for October Release

Bellwether Stocks Movement
·
Sep 22

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Moderna Provides Details on Data Presentations at Upcoming Conferences

MT Newswires Live
·
Sep 22

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

TIPRANKS
·
Sep 22

Moderna Inc Stock (MRNA) Moved Up by 14.21% on Sep 21: Drivers Behind the Movement

TradingKey
·
Sep 22

Moderna Stock Jumps. Its mRNA Cancer Vaccine is Getting Ready for Its Next Big Test.

Dow Jones
·
Sep 22

Moderna to Present Late-Breaking Phase 3 Melanoma Data for Intismeran Autogene at ESMO 2026

Reuters
·
Sep 22

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 22

Moderna announces late-breaking data to be presented at ESMO Congress 2026

TIPRANKS
·
Sep 21

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

GlobeNewswire
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Moderna stock rises 8%: can it continue its cancer vaccine success rally?

Bellwether Stocks Movement
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18